|
US10905A
(en)
|
|
1854-05-16 |
|
Lath-machine |
|
US509002A
(en)
|
|
1893-11-21 |
|
Eleotbic bail way |
|
US570802A
(en)
|
|
1896-11-03 |
|
Nicholas powell horton |
|
FR901228A
(fr)
|
1943-01-16 |
1945-07-20 |
Deutsche Edelstahlwerke Ag |
Système d'aimant à entrefer annulaire
|
|
GB8601597D0
(en)
|
1986-01-23 |
1986-02-26 |
Wilson R H |
Nucleotide sequences
|
|
US6352694B1
(en)
|
1994-06-03 |
2002-03-05 |
Genetics Institute, Inc. |
Methods for inducing a population of T cells to proliferate using agents which recognize TCR/CD3 and ligands which stimulate an accessory molecule on the surface of the T cells
|
|
US6905680B2
(en)
|
1988-11-23 |
2005-06-14 |
Genetics Institute, Inc. |
Methods of treating HIV infected subjects
|
|
US6534055B1
(en)
|
1988-11-23 |
2003-03-18 |
Genetics Institute, Inc. |
Methods for selectively stimulating proliferation of T cells
|
|
US5858358A
(en)
|
1992-04-07 |
1999-01-12 |
The United States Of America As Represented By The Secretary Of The Navy |
Methods for selectively stimulating proliferation of T cells
|
|
US5585362A
(en)
|
1989-08-22 |
1996-12-17 |
The Regents Of The University Of Michigan |
Adenovirus vectors for gene therapy
|
|
US5283173A
(en)
|
1990-01-24 |
1994-02-01 |
The Research Foundation Of State University Of New York |
System to detect protein-protein interactions
|
|
JPH11508121A
(ja)
|
1990-03-22 |
1999-07-21 |
ザ ソーク インスティテュート フォア バイオロジカル スタディーズ |
昆虫レチノイドレセプター組成物および方法
|
|
IE913929A1
(en)
|
1990-11-13 |
1992-05-20 |
Immunex Corp |
Bifunctional selectable fusion genes
|
|
US5350674A
(en)
|
1992-09-04 |
1994-09-27 |
Becton, Dickinson And Company |
Intrinsic factor - horse peroxidase conjugates and a method for increasing the stability thereof
|
|
AU6953394A
(en)
|
1993-05-21 |
1994-12-20 |
Targeted Genetics Corporation |
Bifunctional selectable fusion genes based on the cytosine deaminase (cd) gene
|
|
US7175843B2
(en)
|
1994-06-03 |
2007-02-13 |
Genetics Institute, Llc |
Methods for selectively stimulating proliferation of T cells
|
|
ATE293699T1
(de)
|
1995-03-03 |
2005-05-15 |
Syngenta Participations Ag |
Kontrolle der pflanzengenexpression durch rezeptor-vermittelte transaktivation in gegenwart von einem chemischen ligand
|
|
CA2214649C
(en)
|
1995-03-08 |
2007-06-12 |
Zeling Cai |
Antigen presenting system and methods for activation of t-cells
|
|
US7067318B2
(en)
|
1995-06-07 |
2006-06-27 |
The Regents Of The University Of Michigan |
Methods for transfecting T cells
|
|
US6692964B1
(en)
|
1995-05-04 |
2004-02-17 |
The United States Of America As Represented By The Secretary Of The Navy |
Methods for transfecting T cells
|
|
US5885827A
(en)
|
1996-01-23 |
1999-03-23 |
The Regents Of The Universtiy Of California |
Eukaryotic high rate mutagenesis system
|
|
AU734051B2
(en)
|
1996-04-05 |
2001-05-31 |
Salk Institute For Biological Studies, The |
Hormone-mediated methods for modulating expression of exogenous genes in mammalian systems, and products related thereto
|
|
ES2278390T3
(es)
|
1996-05-23 |
2007-08-01 |
The Scripps Research Institute |
Sistema de presentacion de antigenos de clase ii de cmh y procedimientos de activacion de linfocitos t cd4+.
|
|
ATE466948T1
(de)
|
1997-03-11 |
2010-05-15 |
Univ Minnesota |
Dns-basiertes transposon-system für die einführung von nucleinsäure in die dns einer zelle
|
|
EP0998560A1
(en)
|
1997-07-10 |
2000-05-10 |
The Salk Institute For Biological Studies |
Modified lepidopteran receptors and hybrid multifunctional proteins for use in regulation of transgene expression
|
|
US6333318B1
(en)
|
1998-05-14 |
2001-12-25 |
The Salk Institute For Biological Studies |
Formulations useful for modulating expression of exogenous genes in mammalian systems, and products related thereto
|
|
US6790662B1
(en)
|
1999-03-12 |
2004-09-14 |
Ortho-Mcneil Pharmaceutical, Inc. |
Method of isolating CD8+ cells, and related hybridoma cells antibodies and polypeptides
|
|
HK1047109A1
(zh)
|
1999-10-15 |
2003-02-07 |
University Of Massachusetts |
作为指定基因干预工具的rna干预轨迹基因
|
|
WO2001030965A2
(en)
|
1999-10-28 |
2001-05-03 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods of in vivo gene transfer using a sleeping beauty transposon system
|
|
US6326193B1
(en)
|
1999-11-05 |
2001-12-04 |
Cambria Biosciences, Llc |
Insect control agent
|
|
US6867041B2
(en)
|
2000-02-24 |
2005-03-15 |
Xcyte Therapies, Inc. |
Simultaneous stimulation and concentration of cells
|
|
US7572631B2
(en)
|
2000-02-24 |
2009-08-11 |
Invitrogen Corporation |
Activation and expansion of T cells
|
|
KR20030032922A
(ko)
|
2000-02-24 |
2003-04-26 |
싸이트 테라피스 인코포레이티드 |
세포의 동시 자극 및 농축
|
|
US6797514B2
(en)
|
2000-02-24 |
2004-09-28 |
Xcyte Therapies, Inc. |
Simultaneous stimulation and concentration of cells
|
|
US20040033600A1
(en)
|
2001-03-21 |
2004-02-19 |
Palli Subba Reddy |
Ecdysone receptor-based inducible gene expression system
|
|
AU2001249315A1
(en)
|
2000-03-22 |
2001-10-03 |
Rheogene, Inc. |
Ecdysone receptor-based inducible gene expression system
|
|
AU2001275474A1
(en)
|
2000-06-12 |
2001-12-24 |
Akkadix Corporation |
Materials and methods for the control of nematodes
|
|
US20020082787A1
(en)
|
2000-07-07 |
2002-06-27 |
Woodworth Robert E. |
Method and apparatus for monitoring a product during shipping, storage and use
|
|
US8105825B2
(en)
|
2000-10-03 |
2012-01-31 |
Intrexon Corporation |
Multiple inducible gene regulation system
|
|
EP1373470B1
(en)
|
2001-02-20 |
2013-04-24 |
Intrexon Corporation |
Novel substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system
|
|
US20040071671A1
(en)
|
2001-02-20 |
2004-04-15 |
Leturcq Didier J. |
Cell therapy method for the treatment of tumors
|
|
JP4955904B2
(ja)
|
2001-02-20 |
2012-06-20 |
イントレキソン コーポレーション |
新規エクジソン受容体／無脊椎動物レチノイドｘ受容体−ベースの誘導性遺伝子発現システム
|
|
WO2002066614A2
(en)
|
2001-02-20 |
2002-08-29 |
Rheogene Holdings, Inc. |
Chimeric retinoid x receptors and their use in a novel ecdysone receptor-based inducible gene expression system
|
|
EP1534738B1
(en)
|
2001-02-20 |
2012-06-20 |
Intrexon Corporation |
Novel substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system
|
|
WO2002081649A2
(en)
|
2001-04-06 |
2002-10-17 |
The Trustees Of The University Of Pennsylvania |
ErbB INTERFACE PEPTIDOMIMETICS AND METHODS OF USE THEREOF
|
|
US7919269B2
(en)
|
2001-09-26 |
2011-04-05 |
Intrexon Corporation |
Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof
|
|
MXPA04002810A
(es)
|
2001-09-26 |
2005-06-06 |
Rheogene Holdings Inc |
Acidos nucleicos receptores de ecdisona de saltarilla, polipeptidos, y sus usos.
|
|
US7745140B2
(en)
|
2002-01-03 |
2010-06-29 |
The Trustees Of The University Of Pennsylvania |
Activation and expansion of T-cells using an engineered multivalent signaling platform as a research tool
|
|
WO2003089618A2
(en)
|
2002-04-22 |
2003-10-30 |
Regents Of The University Of Minnesota |
Transposon system and methods of use
|
|
CA2501870C
(en)
|
2002-10-09 |
2013-07-02 |
Avidex Limited |
Single chain recombinant t cell receptors
|
|
US7985739B2
(en)
|
2003-06-04 |
2011-07-26 |
The Board Of Trustees Of The Leland Stanford Junior University |
Enhanced sleeping beauty transposon system and methods for using the same
|
|
US7935510B2
(en)
|
2004-04-30 |
2011-05-03 |
Intrexon Corporation |
Mutant receptors and their use in a nuclear receptor-based inducible gene expression system
|
|
WO2005118788A2
(en)
|
2004-05-27 |
2005-12-15 |
The Trustees Of The University Of Pennsylvania |
Novel artificial antigen presenting cells and uses therefor
|
|
ATE475669T1
(de)
|
2004-06-29 |
2010-08-15 |
Immunocore Ltd |
Einen modifizierten t-zellen-rezeptor exprimierende zellen
|
|
US9034650B2
(en)
|
2005-02-02 |
2015-05-19 |
Intrexon Corporation |
Site-specific serine recombinases and methods of their use
|
|
GB0523954D0
(en)
*
|
2005-11-24 |
2006-01-04 |
Ucb Celltech |
Bioassays
|
|
CA2643337C
(en)
|
2006-03-01 |
2016-01-12 |
Janssen Pharmaceutica N.V. |
Cancer treatment combining lymphodepleting agent with ctls and cytokines
|
|
JP2009539412A
(ja)
*
|
2006-06-12 |
2009-11-19 |
レセプター バイオロジックス， インコーポレイテッド |
汎細胞表面レセプター特異的な治療薬
|
|
JP5543207B2
(ja)
|
2006-10-04 |
2014-07-09 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
不活性化された人工抗原提示細胞の調製および細胞治療におけるそれらの使用
|
|
US20090075378A1
(en)
|
2007-02-20 |
2009-03-19 |
Anaptysbio, Inc. |
Somatic hypermutation systems
|
|
EP2160461B1
(en)
|
2007-07-04 |
2012-08-08 |
Max-Delbrück-Centrum für Molekulare Medizin (MDC) |
Hyperactive variants of the transposase protein of the transposon system sleeping beauty
|
|
MX2010003371A
(es)
|
2007-09-28 |
2010-05-05 |
Intrexon Corp |
Constructos interruptores genicos terapeuticos y biorreactores para la expresion de moleculas bioterapeuticas y usos de los mismos.
|
|
BRPI0818287A2
(pt)
|
2007-10-08 |
2015-11-03 |
Intrexon Corp |
células dendríticas manipuladas e usos para o tratamento do câncer.
|
|
WO2009054917A1
(en)
|
2007-10-19 |
2009-04-30 |
Amgen Inc. |
Methods of selecting epidermal growth factor receptor (egfr) binding agents
|
|
RU2573912C2
(ru)
|
2008-10-08 |
2016-01-27 |
Интрексон Корпорейшн |
Сконструированные клетки, экспрессирующие множественные иммуномодуляторы, и их применения
|
|
TR201904484T4
(tr)
|
2009-11-03 |
2019-05-21 |
Hope City |
Transdüse T hücre seçimine yönelik kesik epiderimal büyüme faktörü reseptörü (EGFRt).
|
|
JP5508625B2
(ja)
|
2009-12-14 |
2014-06-04 |
トヨタ自動車株式会社 |
車両の制御装置及び車両の制御方法
|
|
KR20130010121A
(ko)
|
2010-03-23 |
2013-01-25 |
인트렉손 코포레이션 |
치료적 단백질을 조건부로 발현하는 벡터，상기 벡터를 포함하는 숙주 세포 및 이의 용도
|
|
US9331524B1
(en)
|
2010-07-03 |
2016-05-03 |
Best Energy Reduction Technologies, Llc |
Method, system and apparatus for monitoring and measuring power usage
|
|
EA201390472A1
(ru)
*
|
2010-10-29 |
2014-02-28 |
Иммьюноджен, Инк. |
Новые молекулы, связывающиеся с egfr, и их иммуноконъюгаты
|
|
JP6189754B2
(ja)
|
2011-03-04 |
2017-08-30 |
イントレキソン コーポレーション |
タンパク質を条件的に発現するベクター
|
|
CA2861491C
(en)
*
|
2012-02-13 |
2020-08-25 |
Seattle Children's Hospital D/B/A Seattle Children's Research Institute |
Bispecific chimeric antigen receptors and therapeutic uses thereof
|
|
WO2013163419A1
(en)
*
|
2012-04-25 |
2013-10-31 |
Ligacept Llc |
Broad spectrum erbb ligand binding molecules and methods for their use
|
|
US9034652B2
(en)
|
2013-03-12 |
2015-05-19 |
Bio-Rad Laboratories, Inc. |
Colloidal Coomassie stain
|
|
CA2913052A1
(en)
|
2013-05-24 |
2014-11-27 |
Board Of Regents, The University Of Texas System |
Chimeric antigen receptor-targeting monoclonal antibodies
|
|
CN104341504B
(zh)
*
|
2013-08-06 |
2017-10-24 |
百奥泰生物科技(广州)有限公司 |
双特异性抗体
|
|
JP2017501712A
(ja)
|
2013-12-18 |
2017-01-19 |
イントレキソン コーポレーション |
単鎖ｉｌ−１２核酸、ポリペプチド、およびそれらの使用
|
|
KR102375998B1
(ko)
|
2014-02-14 |
2022-03-21 |
더 보드 오브 리젠츠 오브 더 유니버시티 오브 텍사스 시스템 |
키메라 항원 수용체 및 제조방법
|
|
US9814215B2
(en)
|
2014-03-11 |
2017-11-14 |
Little Big Cat, Inc. |
Pet toy with telescoping wand with metallic wire
|
|
ES2836743T3
(es)
|
2014-06-02 |
2021-06-28 |
Us Health |
Receptores de antígeno quiméricos que seleccionan como diana CD-19
|
|
BR112017001183A2
(pt)
|
2014-07-21 |
2017-11-28 |
Novartis Ag |
tratamento de câncer usando receptor de antígeno quimérico anti-bcma humanizado
|
|
CN105294682B
(zh)
|
2014-07-26 |
2017-07-07 |
广东东阳光药业有限公司 |
Cdk类小分子抑制剂的化合物及其用途
|
|
TWI751102B
(zh)
|
2014-08-28 |
2022-01-01 |
美商奇諾治療有限公司 |
對ｃｄ１９具專一性之抗體及嵌合抗原受體
|
|
EP3197911A4
(en)
|
2014-09-22 |
2018-06-20 |
Intrexon Corporation |
Improved therapeutic control of heterodimeric and single chain forms of interleukin-12
|
|
US20170333480A1
(en)
|
2014-11-05 |
2017-11-23 |
Board Of Regents, The University Of Texas System |
Gene modified immune effector cells and engineered cells for expansion of immune effector cells
|
|
ES2819553T3
(es)
*
|
2014-12-03 |
2021-04-16 |
Juno Therapeutics Inc |
Métodos y composiciones para terapia celular adoptiva
|
|
BR112017013981A2
(pt)
|
2015-01-26 |
2018-01-02 |
Cellectis |
receptores antigênicos quiméricos com uma única cadeia específicos anti-cll1 (sccars) para imunoterapia de câncer
|
|
WO2017062953A1
(en)
|
2015-10-10 |
2017-04-13 |
Intrexon Corporation |
Improved therapeutic control of proteolytically sensitive, destabilized forms of interleukin-12
|
|
US11815514B2
(en)
|
2015-12-04 |
2023-11-14 |
Juno Therapeutics, Inc. |
Methods and compositions related to toxicity associated with cell therapy
|
|
CA3025667A1
(en)
|
2016-06-08 |
2017-12-14 |
Intrexon Corporation |
Cd33 specific chimeric antigen receptors
|
|
CN108330133B
(zh)
*
|
2017-01-20 |
2020-06-30 |
上海恒润达生生物科技有限公司 |
靶向cd19嵌合抗原受体并对其双重修饰的方法及其用途
|
|
CN110573177A
(zh)
|
2017-04-28 |
2019-12-13 |
尤利乌斯·马克西米利安维尔茨堡大学 |
具有人源化靶向结构域的ror1特异性嵌合抗原受体(car)
|